NEW YORK (Reuters Health) – Among patients undergoing liver transplantation for hepatocellular carcinoma, the risk of recurrence is lower when immunosuppression is based on sirolimus rather than calcineurin…
Dr. Francis Cordova, Medical Director of the Lung Transplantation Program at Temple University School of Medicine, discusses the factors that determine strong and weak candidates for lung transplantation…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Patients with previously untreated multiple myeloma do better when they are given an autologous stem-cell transplant followed by an allogeneic transplant from a…
NEW YORK (Reuters Health) – A low-dose regimen of peginterferon, without ribavirin, produces a sustained virologic response in up to 40% of patients with chronic hepatitis C and…
NEW YORK (Reuters Health) – Restricting fluids excessively during major abdominal surgery, even using an individualized “goal-directed fluid strategy,” increases the risk of hypovolemia and impairs organ function…
NEW YORK (Reuters Health) – The current U.S. system for allocating donated livers – which is based on the Model for End-Stage Liver Disease (MELD) score – is…
NEW YORK (Reuters Health) – After brain death in potential lung donors, a “lung protective” strategy can increase the odds that the lungs will be viable for transplant,…
NEW YORK (Reuters Health) – Putting patients on dialysis before they’re symptomatic offers no survival benefit; on the contrary, it may increase their risk of death, according to…
NEW YORK (Reuters Health) – Rates of acute rejection of lung transplants are not improved when sirolimus is added to the immunosuppressive regimen instead of azathioprine, a multicenter…